Therapeutic effect of endothelin-converting enzyme inhibitor on chronic kidney disease through the inhibition of endoplasmic reticulum stress and the NLRP3 inflammasome

Medicine and Dentistry

• Therapy Effect 100%
• Chronic Kidney Disease 100%
• Endoplasmic Reticulum Stress 100%
• Receptor Family 100%
• Nucleotide Binding Oligomerization Domain Like Receptor 100%
• Pyrin 100%
• Endothelin Converting Enzyme Inhibitor 100%
• Inflammasome 100%
• Endothelin 1 50%
• Endothelin Converting Enzyme 50%
• Epithelial Cell 37%
• Autophagy 37%
• Endothelin 2 37%
• Phosphoramidon 37%
• Oxidative Stress 12%
• Disease Exacerbation 12%
• Chronic Inflammation 12%
• Serositis 12%
• Cell Damage 12%
• Fibrosis 12%
• Proteinuria 12%
• Adenine 12%
• Endothelin System 12%
• Cytotoxicity 12%
• Endothelin 12%
• Kidney Cell 12%

Pharmacology, Toxicology and Pharmaceutical Science

• Therapeutic Effect 100%
• Chronic Kidney Failure 100%
• Endothelin Converting Enzyme Inhibitor 100%
• Pyrin 100%
• Nucleotide Binding Oligomerization Domain Like Receptor 100%
• Inflammasome 100%
• Endothelin 1 50%
• Endothelin Converting Enzyme 50%
• Phosphoramidon 37%
• Endothelin 2 37%
• Inflammation 25%
• Endothelin 25%
• Cytotoxicity 12%
• Disease Exacerbation 12%
• Mouse Model 12%
• Chronic Inflammation 12%
• Cellular Injury 12%
• Adenine 12%
• Fibrosis 12%
• Proteinuria 12%

Immunology and Microbiology

• Endoplasmic Reticulum Stress 100%
• Inflammasome 100%
• NOD-like Receptor 100%
• Autophagy 50%
• Cytotoxicity 16%
• Inflammation Response 16%
• Mouse Model 16%
• Kidney Cell 16%
• Oxidative Stress 16%
• Cell Damage 16%